drugs

Novartis Settles Off-Label Marketing Case Over 6 drugs for $422.5 Million - New York Times
Kansas City StarNovartis Settles Off-Label Marketing Case Over 6 drugs for $422.5 MillionNew York TimesThe Swiss drug giant Novartis is paying $422.5 million to settle criminal and civil investigations into the marketing of the antiseizure ...Novartis to pay millions in fines for off-label marketing of drugPhiladelphia InquirerNovartis Settles Drug-Marketing Charges For $422.5MWall Street JournalConn. AG announces multi-state drug settlementLegal News LineThe National Law Journal�-FiercePharma�-MarketWatchall 393 news articles��

Blog Content